EPA (n3) and AA (n6) both compete for use of the delta-5- desaturase enzyme to be synthesized. Increased dietary intake of animal fats alters fatty acid metabolism in favor of inflammation. There are many chronic diseases associated with elevations of this ratio including cardiovascular disease, mood disorders, and cancer. Increasing dietary intake of fish oils, or omega-3 fatty acid containing foods such as flax, chia, oily fish, or walnuts, can shift delta-5-desaturase activity toward the metabolism of the more beneficial n-3 metabolites.

Decreasing intake of animal fats is also recommended.

This test measures the ratio of arachidonic acid (AA) to eicosapentaenoic acid (EPA) in plasma. This ratio of the principle omega-3 and omega-6 fatty acids is a measure of the body’s eicosanoid balance. Balancing these eicosanoids in the body is an excellent way
for managing heart disease and other chronic and inflammatory processes.

This test measures the ratio of arachidonic acid (AA) to eicosapentaenoic acid (EPA) in plasma. This ratio of the principle omega-3 and omega-6 fatty acids is a measure of the body’s eicosanoid balance. Balancing these eicosanoids in the body is an excellent way
for managing heart disease and other chronic and inflammatory processes.

This test measures the ratio of arachidonic acid (AA) to eicosapentaenoic acid (EPA) in plasma. This ratio of the principle omega-3 and omega-6 fatty acids is a measure of the body’s eicosanoid balance. Balancing these eicosanoids in the body is an excellent way
for managing heart disease and other chronic and inflammatory processes.

This test measures the ratio of arachidonic acid (AA) to eicosapentaenoic acid (EPA) in plasma. This ratio of the principle omega-3 and omega-6 fatty acids is a measure of the body’s eicosanoid balance. Balancing these eicosanoids in the body is an excellent way
for managing heart disease and other chronic and inflammatory processes.

This test measures the ratio of arachidonic acid (AA) to eicosapentaenoic acid (EPA) in plasma. This ratio of the principle omega-3 and omega-6 fatty acids is a measure of the body’s eicosanoid balance. Balancing these eicosanoids in the body is an excellent way
for managing heart disease and other chronic and inflammatory processes.

This test measures the ratio of arachidonic acid (AA) to eicosapentaenoic acid (EPA) in plasma. This ratio of the principle omega-3 and omega-6 fatty acids is a measure of the body’s eicosanoid balance. Balancing these eicosanoids in the body is an excellent way
for managing heart disease and other chronic and inflammatory processes.

Only one omega-6 fatty acid, arachidonic acid (AA), and one omega-3 fatty acid, eicosapentaenoic acid (EPA), make up the AA:EPA ratio. The desirable range for the AA:EPA ratio is 2.5:1 – 11:1. The desirable ranges for the ratio were calculated to correspond to the desirable range for the Omega-3 Index due to the strong relationship among these metrics.

Ab NK (CD56/16) refers to the antibody staining of natural killer (NK) cells to detect the presence of specific surface markers, CD56 and CD16. CD56 is a neural cell adhesion molecule, and CD16 is an Fc receptor. Ab NK (CD56/16) analysis is crucial in identifying and characterizing different subsets of NK cells, including the CD56bright and CD56dim populations, each with distinct functional roles in the immune system.

The biomarker Abnormal Protein Band 1 is part of a blood test called "Protein Electrophoresis". 

Protein electrophoresis is a test that measures specific proteins in the blood. The test separates proteins in the blood based on their electrical charge. The protein electrophoresis test is often used to find abnormal substances called M proteins (the M stands for "monoclonal").

The "Abs. CD 8 Suppressor" biomarker in a T + B-Lymphocyte Differential panel from Labcorp measures the absolute count of CD8 positive suppressor T-cells in the blood. CD8 cells, also known as cytotoxic T cells, play a critical role in the immune system's defense against pathogens and cancer cells by directly destroying infected or malignant cells. The absolute count provides a specific numeric value of these cells, unlike percentage values which only give a proportion relative to other cells.

The biomarker "Abs.CD19+ Lymphs" in the T + B-Lymphocyte Differential panel from Labcorp measures the absolute count of CD19 positive lymphocytes, which are primarily B cells. CD19 is a marker indicating B cell presence, crucial for the adaptive immune response, especially in antibody production. This absolute count provides a specific numerical value rather than a percentage, offering a direct measure of the B cell population in the blood. It's instrumental in diagnosing and monitoring conditions affecting B cell function, such as immunodeficiency disorders, certain types of leukemia, and autoimmune diseases. Understanding variations in these counts is vital for evaluating the immune system's health and function.

CD25 is the receptor for IL2 and is expressed on activated T cells, B cells, and macrophages. CD25 is expressed in certain types of B-cell lymphoma (hairy cell leukemia) and T-cell lymphoma (adult T-cell lymphoma/leukemia [ATLL]).

Why use the CD57 test?

The CD57 test is offered in some clinical laboratories and is being used by some health practitioners to evaluate and follow patients diagnosed with chronic Lyme disease.

What is Lyme disease?

Lyme disease, the most common vector-borne illness in the United States, is caused by Borrelia burgdorferi and transmitted by the bite of the Ixodes sp. tick (the deer tick).

The disease usually begins with erythema migrans, an expanding skin lesion at the site of the tick bite. Within several days or weeks, there is hematogenous dissemination of the spirochetes, and patients may present with dermatologic, neurological, cardiac, and rheumatologic involvement.

CD3+ cells are all T-lymphocytes, which includes both CD4+ and CD8+ lymphocyte cells.

This figure is rarely used for making treatment decisions.

CD3+ cells are all T-lymphocytes, which includes both CD4+ and CD8+ lymphocyte cells.

This figure is rarely used for making treatment decisions.

Absolute CD3 cells, also known as CD3+ cells, refer to a subset of T-lymphocytes that express the CD3 marker on their surface. CD3 is a protein complex and T cell co-receptor involved in activating both cytotoxic T cells (CD8+ naive T cells) and T helper cells (CD4+ naive T cells). 

Absolute CD3 cell count represents the total number of CD3+ cells in a given blood sample. It includes both CD4+ and CD8+ T-lymphocytes, which are subtypes of T cells with different functions.